Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Beatriz Rodriguez-Sanchez, Isaac Aranda-Reneo, Juan Oliva-Moreno & Julio Lopez-Bastida. (2021) Assessing the Effect of Including Social Costs in Economic Evaluations of Diabetes-Related Interventions: A Systematic Review. ClinicoEconomics and Outcomes Research 13, pages 307-334.
Read now
Read now
Timothy Kwa, Gina Zhang, Katie Shepard, Kael Wherry & Sarnath Chattaraj. (2021) The improved survival rate and cost-effectiveness of a 7-day continuous subcutaneous insulin infusion set. Journal of Medical Economics 24:1, pages 837-845.
Read now
Read now
Stephané Roze, Jayne Smith-Palmer, Simona de Portu, Alexis Delbaere, Bonnie de Brouwer & Harold W de Valk. (2019) Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands. ClinicoEconomics and Outcomes Research 11, pages 73-82.
Read now
Read now
Shraddha Chaugule & Claudia Graham. (2017) Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective. Journal of Medical Economics 20:11, pages 1128-1135.
Read now
Read now
Articles from other publishers (25)
Johan Jendle & Yves Reznik. (2023) Use of insulin pumps and closed‐loop systems among people living with diabetes: A narrative review of clinical and cost‐effectiveness to enable access to technology and meet the needs of payers. Diabetes, Obesity and Metabolism 25:S2, pages 21-32.
Crossref
Crossref
Hao Lou, Mei Feng & Michael J. Hageman. (2022) Advanced Formulations/Drug Delivery Systems for Subcutaneous Delivery of Protein-Based Biotherapeutics. Journal of Pharmaceutical Sciences 111:11, pages 2968-2982.
Crossref
Crossref
Yuxin Jiao, Rose Lin, Xinyang Hua, Leonid Churilov, Michele J. Gaca, Steven James, Philip M. Clarke, David O'Neal & Elif I. Ekinci. (2022)
A systematic review: Cost‐effectiveness of continuous glucose monitoring compared to
self‐monitoring
of blood glucose in type 1 diabetes
. Endocrinology, Diabetes & Metabolism 5:6.
Crossref
Crossref
Bairui Tao, Jiao Li, Xue Li & Fengjuan Miao. (2022) Facile synthesize surfactants and binder-free nanoflake Co(OH)2 on CuCo2S4 nanowire for highly sensitive and selective non-enzymatic glucose sensor. Vacuum 199, pages 110953.
Crossref
Crossref
Steven R. Kraaijeveld. (2020) Continuous Glucose Monitoring as a Matter of Justice. HEC Forum 33:4, pages 345-370.
Crossref
Crossref
Anthony Pease, Ella Zomer, Danny Liew, Clement Lo, Arul Earnest & Sophia Zoungas. (2020) Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesis. Systematic Reviews 9:1.
Crossref
Crossref
Ilaria Malandrucco, Benedetta Russo, Fabiana Picconi, Marika Menduni & Simona Frontoni. (2020) Glycemic Status Assessment by the Latest Glucose Monitoring Technologies. International Journal of Molecular Sciences 21:21, pages 8243.
Crossref
Crossref
Anthony PeaseElla ZomerDanny LiewArul EarnestGeorgia SoldatosZanfina AdemiSophia Zoungas. (2020) Cost-Effectiveness Analysis of a Hybrid Closed-Loop System Versus Multiple Daily Injections and Capillary Glucose Testing for Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics 22:11, pages 812-821.
Crossref
Crossref
Stéphane RozeJayne Smith-PalmerSimona de PortuA. Zeynep Özdemir SaltikTuğba AkgülOğuzhan Deyneli. (2019) Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey. Diabetes Technology & Therapeutics 21:12, pages 727-735.
Crossref
Crossref
Partha Pratim Ray. (2018) Continuous glucose monitoring: a systematic review of sensor systems and prospects. Sensor Review 38:4, pages 420-437.
Crossref
Crossref
Martina Vettoretti, Giacomo Cappon, Giada Acciaroli, Andrea Facchinetti & Giovanni Sparacino. (2018) Continuous Glucose Monitoring: Current Use in Diabetes Management and Possible Future Applications. Journal of Diabetes Science and Technology 12:5, pages 1064-1071.
Crossref
Crossref
Ignacio Conget, Pilar Martín-Vaquero, Stéphane Roze, Isabel Elías, Cristina Pineda, María Álvarez, Alexis Delbaere & Francisco Javier Ampudia-Blasco. (2018) Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain. Endocrinología, Diabetes y Nutrición 65:7, pages 380-386.
Crossref
Crossref
Ignacio Conget, Pilar Martín-Vaquero, Stéphane Roze, Isabel Elías, Cristina Pineda, María Álvarez, Alexis Delbaere & Francisco Javier Ampudia-Blasco. (2018) Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain. Endocrinología, Diabetes y Nutrición (English ed.) 65:7, pages 380-386.
Crossref
Crossref
A. Nicolucci, M.C. Rossi, D. D'Ostilio, A. Delbaere, S. de Portu & S. Roze. (2018) Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy. Nutrition, Metabolism and Cardiovascular Diseases 28:7, pages 707-715.
Crossref
Crossref
Anna Wood, David O'Neal, John Furler & Elif I. Ekinci. (2018) Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges. Internal Medicine Journal 48:5, pages 499-508.
Crossref
Crossref
George Grunberger, Yehuda Handelsman, ZacharyT Bloomgarden, Vivian A. Fonseca, Alan J. Garber, Richard A. Haas, Victor L. Roberts & Guillermo E. Umpierrez. (2018) American Association of Clinical Endocrinologists And American College of Endocrinology 2018 Position Statement On Integration of Insulin Pumps And Continuous Glucose Monitoring In Patients With Diabetes Mellitus. Endocrine Practice 24:3, pages 302-308.
Crossref
Crossref
Robert Engler, Timothy L. Routh & Joseph Y. Lucisano. (2018) Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys. Clinical Diabetes 36:1, pages 50-58.
Crossref
Crossref
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M. Bergenstal, Kelly L. Close, J. Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A. AmielRoy Beck, Emanuele Bosi, Bruce Buckingham, Claudio Cobelli, Eyal Dassau, Francis J. DoyleIIIIII, Simon Heller, Roman HovorkaWeiping Jia, Tim Jones, Olga Kordonouri, Boris Kovatchev, Aaron Kowalski, Lori Laffel, David Maahs, Helen R. MurphyKirsten Nørgaard, Christopher G. Parkin, Eric Renard, Banshi Saboo, Mauro Scharf, William V. Tamborlane, Stuart A. Weinzimer & Moshe Phillip. (2017) International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 40:12, pages 1631-1640.
Crossref
Crossref
David Russell‐Jones, Simon R. Heller, Sarah Buchs, Anna Sandberg, William J. Valentine & Barnaby Hunt. (2017)
Projected long‐term outcomes in patients with type 1 diabetes treated with fast‐acting insulin aspart vs conventional insulin aspart in the
UK
setting
. Diabetes, Obesity and Metabolism 19:12, pages 1773-1780.
Crossref
Crossref
Johan Jendle, Jayne Smith-Palmer, Alexis Delbaere, Simona de Portu, Natalie Papo, William Valentine & Stéphane Roze. (2017) Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden. Diabetes Therapy 8:5, pages 1015-1030.
Crossref
Crossref
Giacomo Cappon, Giada Acciaroli, Martina Vettoretti, Andrea Facchinetti & Giovanni Sparacino. (2017) Wearable Continuous Glucose Monitoring Sensors: A Revolution in Diabetes Treatment. Electronics 6:3, pages 65.
Crossref
Crossref
Claudia Graham. (2017) Continuous Glucose Monitoring and Global Reimbursement: An Update. Diabetes Technology & Therapeutics 19:S3, pages S-60-S-66.
Crossref
Crossref
Christopher G. Parkin, Claudia Graham & John Smolskis. (2017) Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization. Journal of Diabetes Science and Technology 11:3, pages 522-528.
Crossref
Crossref
Isabelle Steineck, Ajenthen Ranjan, Kirsten Nørgaard & Signe Schmidt. (2016) Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes. Journal of Diabetes Science and Technology 11:1, pages 50-58.
Crossref
Crossref
David Rodbard. (2016) Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. Diabetes Technology & Therapeutics 18:S2, pages S2-3-S2-13.
Crossref
Crossref